Moderna
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Trade Moderna 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About MRNA
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics.
CEOStéphane Bancel
CEOStéphane Bancel
Employees5,800
Employees5,800
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2010
Founded2010
Employees5,800
Employees5,800
MRNA Key Statistics
Market cap12.09B
Market cap12.09B
Price-Earnings ratio-3.69
Price-Earnings ratio-3.69
Dividend yield—
Dividend yield—
Average volume9.07M
Average volume9.07M
High today$32.58
High today$32.58
Low today$30.97
Low today$30.97
Open price$32.45
Open price$32.45
Volume7.82M
Volume7.82M
52 Week high$126.42
52 Week high$126.42
52 Week low$23.15
52 Week low$23.15
MRNA News
Simply Wall St 13h
Moderna, Inc.'s Price Is Right But Growth Is Lacking After Shares Rocket 26%Moderna, Inc. ( ) shareholders have had their patience rewarded with a 26% share price jump in the last month. Still, the 30-day jump doesn't change the fact th...
Simply Wall St 6d
Moderna (NasdaqGS:MRNA) Added to Russell Midcap Indexesrecently experienced significant index changes, with the company being added to the Russell Midcap and Midcap Value indexes, while being dropped from several ot...
Analyst ratings
64%
of 28 ratingsBuy
21.4%
Hold
64.3%
Sell
14.3%
People also own
Based on the portfolios of people who own MRNA. This list is generated using Robinhood data, and it’s not a recommendation.